RePORT International What’s New

This report provides an overview of the latest TB epidemiological situation. It is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control.

The global burden of tuberculosis infection and the need to prevent progression to active disease highlight the importance of generating robust and policy-relevant evidence for tuberculosis preventive treatment (TPT). This guidance presents a structured framework to support the generation of high-quality evidence on new TPT regimens, addressing persistent limitations in available data, including low certainty of evidence, incomplete reporting and insufficient consideration of key decision-making criteria.

In 2026, WHO released new policy recommendations on the new class of NPOC-NAATs, use of tongue swabs as a new sample type to diagnose TB among people that cannot produce sputum (cough up mucus from the lungs), and spooling of sputum samples from multiple patients as a new strategy to diagnose TB that can provide clients with faster results and save programme costs during times of increased financial constraints. The Frequently Asked Questions (FAQ) below are the most common that WHO has received since the new recommendations were published. FAQ responses aim to improve shared understanding of the new policy guidance.

This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral therapy, preventing vertical transmission, and enhancing tuberculosis prevention among individuals with HIV. These updates are intended to support global initiatives aimed at ending AIDS as a public health threat by 2030. Key changes include the introduction of new antiretroviral drugs and regimens, revised postnatal prophylaxis and breastfeeding guidelines for managing infants at risk of vertical transmission, and the endorsement of shorter tuberculosis preventive treatments to improve efficacy and adherence. The recommendations are designed to simplify and advance HIV care, promote equity, and contribute to improved health outcomes and quality of life for individuals living with HIV. The updated guidance will be incorporated into the forthcoming revision of the antiretroviral therapy chapter within the Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery, and Monitoring: Recommendations for a Public Health Approach.

The World Health Organization (WHO), in collaboration with the TB Europe Coalition, is hosting a series of international #EndTB webinars dedicated to advancing the implementation of the Multisectoral Accountability Framework to End TB (MAF-TB). The series serves as an interactive platform for countries and partners to exchange experiences, share best practices, and discuss practical approaches to operationalizing MAF-TB at national and regional levels. The second special session focused on catalysing action to address the social determinants and key drivers of TB through the implementation of MAF-TB. It highlighted how strengthened collaboration across the social protection, labour, justice, and nutrition sectors can accelerate progress towards ending TB.

The World Health Organization (WHO), in collaboration with the TB Europe Coalition (TBEC) convened a global webinar on the operationalization of WHO‚ Multisectoral Accountability Framework to End TB (MAF-TB). This webinar showcased how countries and partners are translating the MAF-TB into practice, transforming commitments into concrete actions to drive accountability and accelerate progress towards ending TB.

Learn how material support can boost TB treatment adherence by reducing economic barriers like transport or medication costs. This module explores practical aid strategies, needs assessment, and building partnerships to support people with TB. Participants should have a general understanding of TB as a disease, including its symptoms, transmission, treatment and social support. Basic experience in working with people affected by TB or other health conditions, especially in community or social support settings, is helpful. No advanced medical knowledge is required, but familiarity with patient interaction and service delivery will support better understanding of the course content.

Learn how to analyse, interpret, and present routine TB surveillance data and how to make use of your findings to generate hypotheses for further investigation and planning programmatic responses. This course draws on basic principles of epidemiology which are applied to TB surveillance data, also covered in the Understanding and using tuberculosis data handbook. Learners should also consult the Consolidated guidance on tuberculosis data generation and use: module 1: tuberculosis surveillance for an up-to-date set of recommendations. Examples, practice exercises and case studies are based on reported findings from conducting national TB epidemiological reviews which follow a standardized terms of reference, implementation methodology and analytical plan.

This module outlines cost components, data sources, and principles for standardised care packages, with step-by-step guidance and an Excel tool to calculate unit costs using built-in formulas and linked data sheets. This module introduces the methodology for costing a standardised package of care. It covers cost components, data sources, and key principles, with step-by-step guidance for calculating unit costs. Learners will use an Excel-based tool with pre-set formulas and linked sheets to perform costing exercises. While the tool follows a standard approach, not all cost categories apply to every service—users must review each service description carefully. The module also explains how to define a unit of service and estimate staff time, including all stages of delivery, to ensure accurate costing. Each course/module contains short (up to 10 minutes) video presentations from a speaker of the relative course/module, the main presentation, and reading materials (glossary, lecture, and list of useful resources).

Learn about TB history, symptoms, diagnosis, treatment, patient rights, prevention, and community engagement, including work with key populations and raising awareness to reduce risks and improve care access. Principles include: Addressing TB requires a multifaceted approach, including awareness raising, risk communication, mobilization, and community engagement. Awareness helps individuals understand TB transmission, symptoms, and prevention, encouraging early detection and treatment. Mobilizing communities supports collective action, combats stigma, and promotes check-ups and vaccinations. Meaningful engagement involves communities in decision-making, fostering trust and access to care. Together, these strategies support prevention, reduce stigma, and advocate for better healthcare access.